LIVE
Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video
Bristol-Myers shareholders approve drugmaker's $74 billion deal with Celgene
Business
April 12, 2019
This article is being updated.
Previous article: 'Basically pornography' — Patriots owner Kraft's lawyer argues against prostitution video release
Prev
Next article: Health stocks plunge as uncertainty rises on Obamacare, Congress threatens action on drug prices
Next
via
CNBC
April 12th 2019
MixedTimes.com
Business
Bristol-Myers shareholders approve drugmaker's $74 billion deal with Celgene
Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video